BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 22407156)

  • 1. 90Y PET-based dosimetry after selective internal radiotherapy treatments.
    D'Arienzo M; Chiaramida P; Chiacchiararelli L; Coniglio A; Cianni R; Salvatori R; Ruzza A; Scopinaro F; Bagni O
    Nucl Med Commun; 2012 Jun; 33(6):633-40. PubMed ID: 22407156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 90Y-PET for the assessment of microsphere biodistribution after selective internal radiotherapy.
    Bagni O; D'Arienzo M; Chiaramida P; Chiacchiararelli L; Cannas P; D'Agostini A; Cianni R; Salvatori R; Scopinaro F
    Nucl Med Commun; 2012 Feb; 33(2):198-204. PubMed ID: 22124359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization.
    Martí-Climent JM; Prieto E; Elosúa C; Rodríguez-Fraile M; Domínguez-Prado I; Vigil C; García-Velloso MJ; Arbizu J; Peñuelas I; Richter JA
    Med Phys; 2014 Sep; 41(9):092503. PubMed ID: 25186412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D inpatient dose reconstruction from the PET-CT imaging of 90Y microspheres for metastatic cancer to the liver: feasibility study.
    Fourkal E; Veltchev I; Lin M; Koren S; Meyer J; Doss M; Yu JQ
    Med Phys; 2013 Aug; 40(8):081702. PubMed ID: 23927299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient dosimetry for 90Y selective internal radiation treatment based on 90Y PET imaging.
    Ng SC; Lee VH; Law MW; Liu RK; Ma VW; Tso WK; Leung TW
    J Appl Clin Med Phys; 2013 Sep; 14(5):212-21. PubMed ID: 24036875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
    Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW
    Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
    Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
    J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
    Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
    J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization.
    Tapp KN; Lea WB; Johnson MS; Tann M; Fletcher JW; Hutchins GD
    J Nucl Med; 2014 Sep; 55(9):1452-8. PubMed ID: 24982437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.
    Lhommel R; van Elmbt L; Goffette P; Van den Eynde M; Jamar F; Pauwels S; Walrand S
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1654-62. PubMed ID: 20422185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
    Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
    J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 90Y microsphere therapy: does 90Y PET/CT imaging obviate the need for 90Y Bremsstrahlung SPECT/CT imaging?
    Zade AA; Rangarajan V; Purandare NC; Shah SA; Agrawal AR; Kulkarni SS; Shetty N
    Nucl Med Commun; 2013 Nov; 34(11):1090-6. PubMed ID: 23942324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry.
    D'Arienzo M; Filippi L; Chiaramida P; Chiacchiararelli L; Cianni R; Salvatori R; Scopinaro F; Bagni O
    Ann Nucl Med; 2013 Aug; 27(7):676-80. PubMed ID: 23605058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Microdosimetric Analysis of Absorbed Dose to Tumor as a Function of Number of Microspheres per Unit Volume in 90Y Radioembolization.
    Pasciak AS; Bourgeois AC; Bradley YC
    J Nucl Med; 2016 Jul; 57(7):1020-6. PubMed ID: 26912424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging-based radiation-absorbed dose estimation of 166Ho microspheres in liver radioembolization.
    Seevinck PR; van de Maat GH; de Wit TC; Vente MA; Nijsen JF; Bakker CJ
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e437-44. PubMed ID: 22633554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
    Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
    J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (90)Y-PET/CT Imaging Quantification for Dosimetry in Peptide Receptor Radionuclide Therapy: Analysis and Corrections of the Impairing Factors.
    Fabbri C; Bartolomei M; Mattone V; Casi M; De Lauro F; Bartolini N; Gentili G; Amadori S; Agostini M; Sarti G
    Cancer Biother Radiopharm; 2015 Jun; 30(5):200-10. PubMed ID: 25860616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma.
    Sarfaraz M; Kennedy AS; Lodge MA; Li XA; Wu X; Yu CX
    Med Phys; 2004 Sep; 31(9):2449-53. PubMed ID: 15487724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of yttrium-90 quantitative imaging by TOF and non-TOF PET in a phantom of liver selective internal radiotherapy.
    van Elmbt L; Vandenberghe S; Walrand S; Pauwels S; Jamar F
    Phys Med Biol; 2011 Nov; 56(21):6759-77. PubMed ID: 21970976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.